SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
RNAi
An SI Board Since May 2003
Posts SubjectMarks Bans
671 52 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
646<b>GSK and Regulus to Collaborate on miRNA-Based HCV Drugs</b> GEN idos-2/25/2010
645Significant resolution of IP murk in the offing? The Tuschl patent estate goes tuck-1/20/2010
644Modifying the header and posting link to this blog: "RNAITHERAPEUTICS.BLOGtuck-1/20/2010
643>> Based on the potential for the <b>immune stimulation</b> toscaram(o)uche-1/7/2010
642Two years ago it was almost impossible to publish anything along this line, whicidos112/24/2009
641Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi A.J. Mullen-12/18/2009
640What do you think of MRNA's sale of its nasal delivery technology in April ?Jibacoa-9/24/2009
639Sirna-034 for HCV was another flop.DewDiligence_on_SI-6/14/2009
638Despite these hurdles, I still believe those that survive (like ALNY) will succeidos-6/14/2009
637On known siRNA hurdles that were discussed before by Dew on another board (and Qidos-5/29/2009
636Sorry for the misplaced cookie. See I ate it: :) liebertonline.com And one nidos-5/22/2009
635Thanks for the links, idos. One thing to note, the portion "?cookieSet=1&qtnsaf-5/22/2009
634"This is perhaps the most comprehensive review on siRNAs and innate immunitidos-5/20/2009
633<i> "RNAi has an unbelievable potential to manage cancer and treat itDewDiligence_on_SI-5/17/2009
6321: Oligonucleotides. 2009 May 14. [Epub ahead of print]Click here to read sienzyme-5/17/2009
631Basic research: Contact: Debra Kain ddkain@ucsd.edu 619-543-6163 University of idos-5/17/2009
630<i>In the published work, which was funded by UMMS and the National Institscaram(o)uche-4/30/2009
629Could be a breakthrough. Wed Apr 29 10:33:18 2009 (University of Massachusetts idos-4/30/2009
628On miRNA's involvement in hearing <b>Tel Aviv U research holds out hoidos-4/14/2009
627Ambati strikes again: <b>Ambati study published in PNAS</b> biocetidos-4/7/2009
626Alnylam and Isis invest $20M into Regulus: biz.yahoo.comidos-3/5/2009
625Alnylam Receives Grant of New Patent Broadly Covering RNAi Therapeutics <fromA.J. Mullen-2/10/2009
624<b>Knocking down barriers: advances in siRNA delivery</b> nature.coidos-2/2/2009
623Oops, I didn't notice that the image was divided. Here's the bottom halfidos-1/30/2009
622Thanks, but let me remind you of a couple more: Pfizer is in Phase II with QuarkA.J. Mullen-1/30/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News